vs
Cadre Holdings, Inc.（CDRE）与Envoy Medical, Inc.（COCH）财务数据对比。点击上方公司名可切换其他公司
Cadre Holdings, Inc.的季度营收约是Envoy Medical, Inc.的2229.7倍（$167.2M vs $75.0K）。Cadre Holdings, Inc.净利率更高（7.0% vs -8781.3%，领先8788.4%）。Envoy Medical, Inc.同比增速更快（78.6% vs -5.0%）。Cadre Holdings, Inc.自由现金流更多（$18.0M vs $-5.9M）。过去两年Envoy Medical, Inc.的营收复合增速更高（12.7% vs 10.1%）
Cadre Holdings, Inc.是美国金融科技企业，面向个人及机构客户提供房地产投资项目直投渠道，覆盖纽约等地的商业地产。公司打造的投资平台支持投资者自主选择参与的具体交易项目，且投资门槛远低于全额收购物业所需资金，让不动产投资变得更接近股票交易，获得财经媒体的广泛认可。
Envoy Medical是一家专注于植入式听力解决方案研发和商业化的医疗科技企业，核心产品为全植入式中耳听力设备，主要服务于使用常规外置助听器效果不佳的感音神经性听力损失患者，市场覆盖北美、欧洲等地区。
CDRE vs COCH — 直观对比
营收规模更大
CDRE
是对方的2229.7倍
$75.0K
营收增速更快
COCH
高出83.5%
-5.0%
净利率更高
CDRE
高出8788.4%
-8781.3%
自由现金流更多
CDRE
多$23.8M
$-5.9M
两年增速更快
COCH
近两年复合增速
10.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $167.2M | $75.0K |
| 净利润 | $11.7M | $-6.6M |
| 毛利率 | 43.4% | -181.3% |
| 营业利润率 | 12.2% | -8513.3% |
| 净利率 | 7.0% | -8781.3% |
| 营收同比 | -5.0% | 78.6% |
| 净利润同比 | -9.6% | -42.6% |
| 每股收益（稀释后） | $0.22 | $-0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDRECOCH
| Q4 25 | $167.2M | $75.0K | ||
| Q3 25 | $155.9M | $42.0K | ||
| Q2 25 | $157.1M | $78.0K | ||
| Q1 25 | $130.1M | $46.0K | ||
| Q4 24 | $176.0M | $42.0K | ||
| Q3 24 | $109.4M | $56.0K | ||
| Q2 24 | $144.3M | $68.0K | ||
| Q1 24 | $137.9M | $59.0K |
净利润CDRECOCH
| Q4 25 | $11.7M | $-6.6M | ||
| Q3 25 | $10.9M | $-6.5M | ||
| Q2 25 | $12.2M | $-5.7M | ||
| Q1 25 | $9.2M | $-5.0M | ||
| Q4 24 | $13.0M | $-4.6M | ||
| Q3 24 | $3.7M | $-6.0M | ||
| Q2 24 | $12.6M | $-3.9M | ||
| Q1 24 | $6.9M | $-6.3M |
毛利率CDRECOCH
| Q4 25 | 43.4% | -181.3% | ||
| Q3 25 | 42.7% | -383.3% | ||
| Q2 25 | 40.9% | -200.0% | ||
| Q1 25 | 43.1% | -391.3% | ||
| Q4 24 | 43.9% | -273.8% | ||
| Q3 24 | 36.6% | -233.9% | ||
| Q2 24 | 40.6% | -260.3% | ||
| Q1 24 | 41.8% | -159.3% |
营业利润率CDRECOCH
| Q4 25 | 12.2% | -8513.3% | ||
| Q3 25 | 12.0% | -13590.5% | ||
| Q2 25 | 9.3% | -6500.0% | ||
| Q1 25 | 10.4% | -11102.2% | ||
| Q4 24 | 16.7% | -10828.6% | ||
| Q3 24 | 5.0% | -8878.6% | ||
| Q2 24 | 13.8% | -7135.3% | ||
| Q1 24 | 8.7% | -8278.0% |
净利率CDRECOCH
| Q4 25 | 7.0% | -8781.3% | ||
| Q3 25 | 7.0% | -15433.3% | ||
| Q2 25 | 7.8% | -7294.9% | ||
| Q1 25 | 7.1% | -10865.2% | ||
| Q4 24 | 7.4% | -10995.2% | ||
| Q3 24 | 3.3% | -10642.9% | ||
| Q2 24 | 8.7% | -5804.4% | ||
| Q1 24 | 5.0% | -10627.1% |
每股收益（稀释后）CDRECOCH
| Q4 25 | $0.22 | $-0.27 | ||
| Q3 25 | $0.27 | $-0.35 | ||
| Q2 25 | $0.30 | $-0.32 | ||
| Q1 25 | $0.23 | $-0.29 | ||
| Q4 24 | $0.32 | $-0.40 | ||
| Q3 24 | $0.09 | $-0.39 | ||
| Q2 24 | $0.31 | $-0.29 | ||
| Q1 24 | $0.18 | $-0.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $122.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $317.8M | $-12.2M |
| 总资产 | $770.0M | $8.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDRECOCH
| Q4 25 | $122.9M | — | ||
| Q3 25 | $150.9M | — | ||
| Q2 25 | $137.5M | — | ||
| Q1 25 | $133.4M | — | ||
| Q4 24 | $124.9M | — | ||
| Q3 24 | $93.0M | — | ||
| Q2 24 | $105.9M | — | ||
| Q1 24 | $87.1M | — |
股东权益CDRECOCH
| Q4 25 | $317.8M | $-12.2M | ||
| Q3 25 | $340.4M | $-7.7M | ||
| Q2 25 | $332.5M | $-29.9M | ||
| Q1 25 | $317.6M | $-24.2M | ||
| Q4 24 | $311.5M | $-18.8M | ||
| Q3 24 | $300.3M | $-18.5M | ||
| Q2 24 | $299.4M | $-12.4M | ||
| Q1 24 | $270.7M | $-7.4M |
总资产CDRECOCH
| Q4 25 | $770.0M | $8.6M | ||
| Q3 25 | $792.1M | $8.2M | ||
| Q2 25 | $794.4M | $9.9M | ||
| Q1 25 | $656.3M | $10.4M | ||
| Q4 24 | $652.7M | $11.5M | ||
| Q3 24 | $616.6M | $9.4M | ||
| Q2 24 | $620.6M | $6.7M | ||
| Q1 24 | $599.4M | $8.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.3M | $-5.7M |
| 自由现金流经营现金流 - 资本支出 | $18.0M | $-5.9M |
| 自由现金流率自由现金流/营收 | 10.7% | -7809.3% |
| 资本支出强度资本支出/营收 | 2.0% | 229.3% |
| 现金转化率经营现金流/净利润 | 1.81× | — |
| 过去12个月自由现金流最近4个季度 | $56.8M | — |
8季度趋势，按日历期对齐
经营现金流CDRECOCH
| Q4 25 | $21.3M | $-5.7M | ||
| Q3 25 | $22.5M | $-4.3M | ||
| Q2 25 | $2.6M | $-4.5M | ||
| Q1 25 | $17.4M | $-3.7M | ||
| Q4 24 | $23.7M | $-5.1M | ||
| Q3 24 | $-5.2M | $-2.6M | ||
| Q2 24 | $11.1M | $-4.6M | ||
| Q1 24 | $2.1M | $-5.6M |
自由现金流CDRECOCH
| Q4 25 | $18.0M | $-5.9M | ||
| Q3 25 | $21.6M | — | ||
| Q2 25 | $1.2M | $-4.5M | ||
| Q1 25 | $16.1M | $-3.7M | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $-6.2M | $-3.8M | ||
| Q2 24 | $9.1M | — | ||
| Q1 24 | $794.0K | $-5.7M |
自由现金流率CDRECOCH
| Q4 25 | 10.7% | -7809.3% | ||
| Q3 25 | 13.9% | — | ||
| Q2 25 | 0.7% | -5719.2% | ||
| Q1 25 | 12.4% | -8110.9% | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | -5.7% | -6750.0% | ||
| Q2 24 | 6.3% | — | ||
| Q1 24 | 0.6% | -9657.6% |
资本支出强度CDRECOCH
| Q4 25 | 2.0% | 229.3% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.9% | 1.3% | ||
| Q1 25 | 1.0% | 13.0% | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.9% | 2066.1% | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.0% | 184.7% |
现金转化率CDRECOCH
| Q4 25 | 1.81× | — | ||
| Q3 25 | 2.05× | — | ||
| Q2 25 | 0.21× | — | ||
| Q1 25 | 1.88× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | -1.43× | — | ||
| Q2 24 | 0.89× | — | ||
| Q1 24 | 0.31× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDRE
| U.s.state And Local Agencies | $72.7M | 43% |
| Other | $48.6M | 29% |
| U.s.Federal Agencies | $31.6M | 19% |
| Commercial | $12.0M | 7% |
COCH
暂无分部数据
